SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders react to contradictory signals regarding the Iran conflict, with markets weighing optimistic peace deal rumors against reports of continued military escalation and supply chain disruptions. The community remains deeply divided, with many actively debating whether the current price action represents a speculative bubble prone to a sharp correction or a sustained rally driven by real-world constraints on the Strait of Hormuz.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is facing significant downward pressure as investors react to escalating geopolitical tensions in the Middle East and a sharp spike in oil prices, fueling fears of inflation and economic instability. Community sentiment remains highly divided and volatile, with market participants debating whether the current selloff is a necessary market correction or a result of artificial manipulation following conflicting leadership signals regarding the conflict.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing heightened volatility as investors react to a lack of clear resolution in the ongoing Iran conflict, leading to widespread skepticism toward recent market rallies. Community discourse is dominated by debates over geopolitical instability, the impact of fluctuating oil prices, and deep frustration with what many perceive as market manipulation driven by inconsistent political rhetoric.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community actively debate the economic and geopolitical implications of the former President's latest address regarding the Iran conflict. The discussion is heavily polarized, with critics pointing to market volatility and concerns over rhetoric, while supporters remain focused on political alignment and ongoing market strategies.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending following the announcement of a new contract from a NATO ally for its Black Widow drones, sparking intense debate among community members regarding the company's long-term contract visibility versus ongoing volatility and dilution concerns. Investors are actively discussing the stock's role in the broader defense sector, with many focused on how recent strategic partnerships and government procurement trends might impact future growth.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently experiencing heightened volatility as investors weigh the company's long-term potential for space-based cellular connectivity against a broader market sell-off fueled by geopolitical instability in the Middle East. The community remains deeply divided, with bulls pointing to the upcoming Bluebird 7 launch and institutional backing as core catalysts for a recovery, while bears are increasingly focused on launch delays and the stock's recent technical breakdown.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the focal point of intense market sentiment as investors weigh volatile geopolitical headlines against high-stakes Q1 delivery expectations. Community discourse is sharply divided between bulls banking on a delivery beat and AI-driven growth, and bears highlighting potential margin compression, regulatory headwinds, and the broader risks of a tech-heavy portfolio in a cooling demand environment.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market volatility and increased volume as speculation mounts over a potential acquisition by tech giants like Amazon or SpaceX, with the community actively debating whether current buyout rumors are substantiated or merely a play for leverage. Traders are closely tracking the intersection of GSAT's critical satellite spectrum assets, the long-standing Apple partnership, and the broader space industry land-grab for direct-to-device connectivity.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders debate the sustainability of the semiconductor sector's prolonged rally amidst ongoing geopolitical tensions and high oil prices. While some community members are betting on a major correction, arguing that AI-driven valuation expansion is reaching a breaking point, others warn against shorting an essential industry during a cycle where hardware demand remains a critical component of national security.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Lipocine is currently trending as investors focus on the company's progress with LPCN 1154 for postpartum depression, following the primary endpoint miss in a recent trial. The community is actively debating the company's future development path and potential for strategic partnerships, as stakeholders analyze the stock's long-term viability amid ongoing cash management and pipeline evaluations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PRME invest in this to take advantage of the current biotech hype but dont forget this is still at least 3-5 years and $250-500 million away from its first clinical approval. their pipeline is thin, mostly discovery stage, and the indications theyre targeting are already being targeted by other editing companies that are ahead by multiple years. as of june 2025 they have $115 million in cash- i dont see a future where they dont need to dilute more, ideally they take advantage of a price swing upward to fundraise. not bearish, just being realistic here! this is a 10-15 year play, whereas NTLA and CRSP are more solid 5 year plays.

MADE YOU LOOK

Deet Mesquite

LotOfAction

G_Money_888

StockTwits for iOS

Prime Medicine Inc

 invest in this to take advantage of the current biotech hype but dont forget this is still at least 3-5 years and $250-500 million away from its first clinical approval. their pipeline is thin, mostly discovery stage, and the indications theyre targeting are already being targeted by other editing companies that are ahead by multiple years. as of june 2025 they have $115 million in cash- i dont see a future where they dont need to dilute more, ideally they take advantage of a price swing upward to fundraise. not bearish, just being realistic here! this is a 10-15 year play, whereas NTLA and CRSP are more solid 5 year plays.

Netflix Inc

Vertex Pharmaceuticals, Inc.

uniQure NV

CRISPR Therapeutics AG

Wave Life Sciences Ltd

Robinhood Markets Inc

Tempus AI Inc

Block Inc

MS Biotechnology

@mikeg1999 CRSP is old tech, we’re coming for you

 CRSP is old tech, we’re coming for you

Oracle Corp.

Intellia Therapeutics Inc

Personalis Inc

Fractyl Health Inc.

Publius Valerius

@Publicola29 it’s not about the tech, its about how you employ it in the right indications and execute on development. it’s how you interact with KOLs and build a reputation and brand. the tech is baseline, they all do the same thing. dont be naive

 it’s not about the tech, its about how you employ it in the right indications and execute on development. it’s how you interact with KOLs and build a reputation and brand. the tech is baseline, they all do the same thing. dont be naive

@mikeg1999 double stranded cuts aren’t safe

@mikeg1999 it’s not about the tech crisper can’t do what priming can do. How is that not about the tech? I don’t mention they make double stranded brakes double stranded cuts which leads to unwanted results prime editing is the future do this guy about to drop news that one drug is gonna be able to treat multiple diseases get in here.

 it’s not about the tech crisper can’t do what priming can do. How is that not about the tech? I don’t mention they make double stranded brakes double stranded cuts which leads to unwanted results prime editing is the future do this guy about to drop news that one drug is gonna be able to treat multiple diseases get in here.

@Publicola29 dude. sure, their biological mechanisms are inherently different. sure there may be diseases where editing a single base pair with a single strand or no DNA cut might make more sense, but look at PRIME’s preclinical pipeline - ex vivo CAR-Ts, AATD, CF… all gene editing companies are going after one or more of those same indications, bc all their technologies can edit genes, whether its a knock in or knock out. CRISPR dsbs can be deleterious if the dosing/gRNA specificity is not optimal, but the robustness of early stage screening and sequencing/AI modeling/proof of concept data theyve built from previous candidates, CRISPR can be used safely and have the same impact on disease state as prime editing.

 dude. sure, their biological mechanisms are inherently different. sure there may be diseases where editing a single base pair with a single strand or no DNA cut might make more sense, but look at PRIME’s preclinical pipeline - ex vivo CAR-Ts, AATD, CF… all gene editing companies are going after one or more of those same indications, bc all their technologies can edit genes, whether its a knock in or knock out. CRISPR dsbs can be deleterious if the dosing/gRNA specificity is not optimal, but the robustness of early stage screening and sequencing/AI modeling/proof of concept data theyve built from previous candidates, CRISPR can be used safely and have the same impact on disease state as prime editing.

@mikeg1999 as Crspr does a $600M offering at 6B mc hahahahH

 as Crspr does a $600M offering at 6B mc hahahahH